Pharma-Bio Serv (PBSV) Income towards Parent Company (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Income towards Parent Company of $32860.0 for Q1 2026, up 284.96% on a YoY basis from $8536.0 in Q1 2025, and up 32315.69% quarter-over-quarter from -$102.0 in Q4 2025.
Pharma-Bio Serv (PBSV) Income towards Parent Company (2010 - 2026) Analysis & Trends
Pharma-Bio Serv has reported Income towards Parent Company for 16 years, with the latest figure at $32860.0 in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 284.96% year-over-year to $32860.0; the trailing twelve-month figure through Jan 2026 stood at -$85697.0 (up 82.8% YoY), and the FY2025 full-year result was -$100463.0, up 87.08% from the prior year.
- Income towards Parent Company for Q1 2026 stood at $32860.0, up from -$102.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $526242.0 in Q3 2023, with the low at -$309194.0 in Q3 2024.
- Historically, Income towards Parent Company has averaged $86004.9 across 5 years, with a median of $32860.0 in 2026.
- Annual changes were most pronounced in 2024 — Income towards Parent Company tumbled 163.48% — and 2026, when it jumped 284.96%.
- Pharma-Bio Serv's Income towards Parent Company stood at $173379.0 in 2022, then slumped by 127.19% to -$47148.0 in 2023, then jumped by 134.17% to $16111.0 in 2024, then tumbled by 100.63% to -$102.0 in 2025, then jumped by 32315.69% to $32860.0 in 2026.
- The last three Income towards Parent Company figures came in at $32860.0 (Q1 2026), -$102.0 (Q4 2025), and -$213808.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |
| Apr 30, 2021 | 240,271.00 |